Augmedics, a pioneer in augmented reality (AR) surgical navigation, has successfully closed an $82.5 million Series D financing round to accelerate the adoption of its xvision technology in spine surgery. The funding will support the company's expansion in the US market and the development of next-generation advancements for its xvision platform.   The xvision technology provides surgeons wi..
Thermo Fisher Scientific has unveiled the Thermo Scientific™ Metrios™ 6 Scanning Transmission Electron Microscope ((S)TEM), a new-generation, fully automated (S)TEM metrology solution that aims to enhance productivity and ensure data quality assurance in high-volume semiconductor manufacturing. The Metrios 6 (S)TEM offers up to 20% average productivity improvement compared to its predecessor, en..
DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico   Mexico City Prospective Study is a strategic collaboration between Universidad Nacional Autónoma de México and Oxford Population Health   MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- DNAnexus, Inc. the leading provider of cloud-based genomic and biomedical data access a..
Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, has announced positive topline results from its first Phase 1 clinical study of FB101. This investigational vaginal microbial immunotherapeutic has shown promising results in treating asymptomatic vaginal dysbiosis. The study was conducted in Europe and evaluated the change in vaginal microbiome after three conse..
Lovell and Freespira Increase Access to FDA-Cleared, Drug-Free PTSD Treatment for Veterans and Military Personnel Published: Jun 27, 2023 Freespira's at-home medical device shown to reduce or lead to remission of symptoms associated with panic disorder and PTSD in 28 days, now available to federal healthcare providers. KIRKLAND, Wash. and PENSACOLA, Fla., June 27, 2023 /PRNewswire/ -- Today, Lov..
City of Hope, one of the largest cancer research and treatment organizations in the United States, presented new research on beta cells, insulin secretion, and islet transplantation at the annual American Diabetes Association (ADA) Conference. The research aims to improve understanding of type 1 and type 2 diabetes and enhance treatment options. The studies conducted by City of Hope scientists f..
SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza   SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, has announced a research collaboration agreement with the Peter Doherty Institute for Infection and Immunity. This collaboration aims to develop a next-generation in..
Inozyme Pharma, a clinical-stage rare disease biopharmaceutical company, has announced the dosing of the first infant with ENPP1 Deficiency in a Phase 1b trial of their drug, INZ-701. The trial, called ENERGY-1, aims to assess the safety and effectiveness of INZ-701 in infants with this condition. ENPP1 Deficiency is a progressive condition that can lead to severe symptoms and high mortality rat..
Oncocyte Begins Manufacturing Transplant Blood Test OncoCyte, Corp. (Nasdaq: OCX), a precision diagnostics company, has announced that it has started the manufacturing process for its patented transplant technology. The test measures levels of donor derived cell-free DNA (dd-cfDNA) in the blood to check for signs of graft damage in transplant recipients. The company plans to launch an early acce..
Ocuphire Pharma, Inc. presented clinical data on their drug APX3330 in a late-breaker session at the American Diabetes Association's Annual Conference. The data showed that APX3330 reduced the worsening of diabetic retinopathy after 24 weeks of treatment. This could potentially shift the treatment paradigm for diabetic retinopathy and broaden the prescriber base to include primary care and endoc..